Product logins

Find logins to all Clarivate products below.


Abeezer Tapia

Senior Vice President and General Manager, Commercial

Abeezer Tapia is a healthcare, life science and technology executive with over 20 years of experience focused on making the strongest possible impact for patients. His experience spans high-growth start-ups to Fortune 500 companies, leading commercial, product and strategic efforts. He most recently served as the Head of Commercial Development at Verily Life Sciences (formerly Google Life Sciences). Prior he was on the leadership team for Health Tech growth companies Aetion and MC10.

Prior to that Abeezer held several global management roles at Medtronic, the world’s largest medical device manufacturer. Abeezer started his career in the technology field at Advanced Micro Devices (AMD). Abeezer holds a Computer and Electrical Engineering degree from Cornell University and an MBA from the Harvard Business School.

Latest news

News April 29, 2025
Clarivate Reports First Quarter 2025 Results

— Accelerated recurring organic revenue growth — — Reaffirmed 2025 Outlook — — Repurchased $50 million ordinary shares — London, UK — April 29, 2025 Clarivate Plc (NYSE: CLVT) (the…

News April 23, 2025
Clarivate Launches DRG Commercial Analytics 360 Enabling Medtech Companies to Advance Commercial Strategy and Execution

New solution provides integrated provider intelligence and real-world data to optimize targeting, strategic planning and patient access across commercial organizations London, U.K. April 23, 2025: Clarivate Plc (NYSE:CLVT), a leading…

News April 23, 2025
Clarivate Releases EndNote 2025 with AI-Powered Research Tools

Enhancing research efficiency and accuracy with newly integrated features

Related resources

Navigating uncertainty: What’s keeping healthcare execs up at night in this new era Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Blog April 2, 2025
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Market Access Pharma Portfolio strategy Regulatory Research commercialization
Five Medtech Trends to Watch in 2025 Five Medtech Trends to Watch in 2025
Blog February 11, 2025
Five Medtech Trends to Watch in 2025
Medical technology Medtech Medtech Resource Center
The trends to watch in 2025 The trends to watch in 2025
Blog January 8, 2025
The trends to watch in 2025
This small biotech notched a big win for rare disease patients with a canny market access strategy This small biotech notched a big win for rare disease patients with a canny market access strategy
Blog December 19, 2024
This small biotech notched a big win for rare disease patients with a canny market access strategy
Market Access